- Home
- AMLX vs DHAI Comparison
AMLX vs DHAI Comparison
Compare AMLX & DHAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- DHAI
- Stock Information
- Founded
- AMLX 2014
- DHAI 2007
- Country
- AMLX United States
- DHAI United States
- Employees
- AMLX N/A
- DHAI N/A
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- DHAI
- Sector
- AMLX Health Care
- DHAI
- Exchange
- AMLX Nasdaq
- DHAI NYSE
- Market Cap
- AMLX 134.0M
- DHAI 68.1M
- IPO Year
- AMLX 2022
- DHAI N/A
- Fundamental
- Price
- AMLX $3.92
- DHAI $1.71
- Analyst Decision
- AMLX Buy
- DHAI
- Analyst Count
- AMLX 7
- DHAI 0
- Target Price
- AMLX $5.20
- DHAI N/A
- AVG Volume (30 Days)
- AMLX 1.4M
- DHAI 28.2K
- Earning Date
- AMLX 11-07-2024
- DHAI 08-19-2024
- Dividend Yield
- AMLX N/A
- DHAI N/A
- EPS Growth
- AMLX N/A
- DHAI N/A
- EPS
- AMLX N/A
- DHAI N/A
- Revenue
- AMLX $298,762,000.00
- DHAI $67,615,000.00
- Revenue This Year
- AMLX N/A
- DHAI N/A
- Revenue Next Year
- AMLX $149.49
- DHAI N/A
- P/E Ratio
- AMLX N/A
- DHAI N/A
- Revenue Growth
- AMLX 55.71
- DHAI 14.15
- 52 Week Low
- AMLX $1.58
- DHAI $0.72
- 52 Week High
- AMLX $19.95
- DHAI $3.67
- Technical
- Relative Strength Index (RSI)
- AMLX 72.38
- DHAI 40.50
- Support Level
- AMLX $3.42
- DHAI $1.67
- Resistance Level
- AMLX $3.48
- DHAI $1.98
- Average True Range (ATR)
- AMLX 0.28
- DHAI 0.19
- MACD
- AMLX 0.06
- DHAI 0.02
- Stochastic Oscillator
- AMLX 65.16
- DHAI 23.16
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.
About DHAI DIH HOLDINGS US INC
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.